[1]
“ELISA AND AUTOIMMUNE BULLOUS DISORDERS IN INDIAN HEALTHCARE CENTRE”, Int. Res. J. Pharm., vol. 12, no. 5, pp. 56–60, May 2021, doi: 10.56802/4zdtxx70.